Xarelto News Update: Court Meeting Took Place to Identify Potential Plaintiffs for Possible Inclusion in Upcoming Bellwether Trials, Says Lawsuitsettlementnews.com

 NEW ORLEANS, July 1, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that in the most recent news of the Xarelto multidistrict litigation, a court meeting was set in which between 40 and 60 plaintiffs were meant to be identified for specific discovery and the timing was to be addressed in the selection of the upcoming bellwether trials. The court released a case management order in May, addressing several different issues at hand. Specific deadlines were set for pre-trial processes so everything could move forward accordingly. The federal multidistrict litigation (MDL) is being overseen in the U.S. District Court in the Eastern District of Louisiana (In Re: Xarelto Products Liability Litigation, No. 2592).

According to court documents, there are currently more than 300 lawsuits filed over Xarelto in the federal litigation in Louisiana, with an additional approximate 160 cases as of now with similar claims pending in Pennsylvania's mass tort proceeding. Lawsuits against Bayer and Johnson & Johnson's subsidiary, Janssen Pharmaceuticals, include claims of serious health problems and even death as a result of uncontrollable bleeding events. There is no known antidote at this time, according to experts.

Chris Janish, CEO of MTS, commented on the recent announcement in the Xarelto multidistrict litigation, "The Xarelto litigation is a litigation that is starting to pick up steam and could reach 1,000 claims in the future. It is a positive sign that the court is already moving to identifypossible bellwether cases to keep the litigation moving in a positive direction."

MTS is ready and able to assist those who need lawsuit help with finding a qualified Xarelto law firm or Xarelto lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Xarelto, Pradaxa, or other blood thinner litigations, please visit: http://www.lawsuitsettlementnews.com/pradaxa-all-blood-thinner-cases

If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Pradaxa or Xarelto usage and/or complications can apply for up to $50K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services

If you, or a loved one, have been injured by Xarelto or Pradaxa and need lawsuit money or lawsuit help, including finding a Xarelto or Pradaxa law firm, call: 877.571.0405.

You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.

Disclaimer: MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page.

Contact:

Chris Janish, CEO

Ph. 877.571.0405

SOURCE MT Services LLC

 

Takeda officials announced that they will put the money into a settlement fund if 95% of plaintiffs agree to participate in the settlement; and if 97% of the plaintiffs sign up, the drug maker would add an additional $300 million, raising the settlement to $2.4 billion, according to Bloomberg News. Settlement awards would be more than $296,000 per case for plaintiffs who choose to participate in the settlement, but settlement amounts may be reduced depending on certain factors such as age, smoking history, and toxin exposure.

Chris Janish, CEO of MTS, commented on the recent Actos settlement, "It is great to see that a litigation over a drug that has produced serious side effects such as bladder cancer is starting to come to a final resolution. Although many patients and their family members will never be the same, a settlement of this size speaks volumes on many levels. Takeda is trying to move forward and also stop new lawsuit claims from coming in, however, possible victims of bladder cancer from Actos should not be deterred and should seek counsel before it is too late to claim their potential award like the rest of the plaintiffs."   

MTS is ready and able to assist those who need lawsuit help with obtaining an Actos law firm or Actos lawyer to provide a free evaluation on their specific case. To learn more about MTS' services involving Actos and other bad drug litigations, please visit: http://www.lawsuitsettlementnews.com/actos-cases

If you already have an attorney and have filed a lawsuit and need a lawsuit funding cash advance or lawsuit money, not to be confused with a lawsuit loan or pre-settlement loan, Lawsuit Settlement News can assist you with these services. Injured parties from Actos usage and/or complications can apply for upto $100K in pre-settlement or settlement lawsuit funding. For a full list of the services that the company provides, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services

If you, or a loved one, have suffered complications from Actos and need lawsuit money or lawsuit help, including finding an Actos attorney or law firm, please call 877.571.0405.

You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.

Disclaimer:  MT Services LLC, operator of Lawsuitsettlementnews.com, is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page.

Contact:

Chris Janish, CEO

Ph. 877.571.0405

SOURCE MT Services LLC